Anti-PD1 Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-PD1 Immunotherapy, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma [Phase 2]